Recent Interesting Articles from TCRN Members

14 October 2020

In this monthly article the TCRN Operations & Projects team use on-line tools to identify publications attributed to TCRN members. We are using Scopus, the largest abstract and citation database of peer-reviewed literature as our primary source.

A “Scopus alert” has been created for any TCRN member who has been an author on a peer-reviewed publication. New results arrive weekly from Scopus, allowing us to create a database of all member publications for the year and then share some recent examples with the TCRN members each month.

Some examples of recent member publications can be seen below. Most university-based members will be able to go directly to the article using the links below. Unfortunately, hospital-based members may be blocked by firewalls and we are unable to find a fix for this problem. Any member who is interested in reading one of these papers but is unable to access them can email and request a PDF copy.

Makker P., White D., Justin L., Parmar J., Goldstein D., Park S., Howells J., Moalem-Taylor G. Acute changes in nerve excitability following oxaliplatin treatment in mice. Journal of Neurophysiology (2020) DOI: 10.1152/jn.00260.2020

Daniels B., Pearson S., Vajdic C., Pottegård A., Buckley N., Zoega H. Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study. Basic and Clinical Pharmacology and Toxicology (2020) DOI: 10.1111/bcpt.13463

Luckett T., Martin A., Currow D., Johnson M., Barnes-Harris M., Phillips J. A systematic review and meta-analysis of studies comparing burden from lung cancer and chronic obstructive pulmonary disease. Palliative Medicine (2020) DOI: 10.1177/0269216320940153

Knox M., Ni J., Bece A., Bucci J., Chin Y., Graham P., Li Y. A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications. Frontiers in Immunology (2020) DOI: 10.3389/fimmu.2020.01612

Best M., Butow P., Jacobs C., Juraskova I., Savard J., Meiser B., Goldstein D., Ballinger M., Bartley N., Napier C., Davies G., Thomas D., Tucker K., Schlub T., Newson A. and Members of the PiGeOn Project. Advanced cancer patient preferences for receiving molecular profiling results. Psycho-Oncology (2020) DOI: 10.1002/pon.5446

Segelov E., Underhill C., Prenen H., Karapetis C., Jackson C., Nott L., Clay T., Pavlakis N., Sabesan S., Heywood E., Steer C., Lethborg C., Gan H., Yip D., Karanth N., Karikios D., MacIntyre R. Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic.JCO Oncology Practice (2020) DOI: 10.1200/OP.20.00229

Jolly C., Pimanda J. Titans awake: HMAs for virus-driven ATL. Blood (2020) DOI: 10.1182/blood.2020006488

Odutola M., Nnakelu E., Giles G., van Leeuwen M., Vajdic C. Lifestyle and risk of follicular lymphoma: a systematic review and meta-analysis of observational studies. Cancer Causes and Control (2020) DOI: 10.1007/s10552-020-01342-9

Diefenbach R., Lee J., Menzies A., Carlino M., Long G., Saw R., Howle J., Spillane A., Scolyer A., Keord R., Rizos H. Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA. Cancers (2020) DOI: 10.3390/cancers12082228

Lyu N., Rajendran V., Diefenbach R., Charles K., Clarke S., Engel A., Sydney 1000 Colorectal Cancer Study Investigators*; Rizos H., Molloy M., Wang Y. Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay. Nanotheranostics (2020) DOI: 10.7150/ntno.48905